Saturday 17 October 2026 Export CYH’s income statement to Excel — free account

Community Health Systems, Inc.

Community Health Systems, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $12.5 billion, down 1.18% from fiscal 2024. In the quarter to June 2026, revenue fell 9.83%, EPS fell 75.8%, free cash flow grew 500.0% and total debt fell 11.8%, each against the same quarter a year earlier.

2.88 0.11 −3.68%

Follow CYH

Alert me

Market cap: $421.6M
P/E: 1.5×
Fwd P/E: −5.2×
Dividend yield: —
F-score: 8/9
Altman Z: 1.05
Beneish M: −2.52
Dividend safety: 35/100

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Insider Decisions trades per month

Total sells 0.12

Totals in millions of $.

	Dec 25			Mar 26			Jun 26			Sep 26
Buy	—	—	—	—	—	—	—	—	—	—	—	—
Sell	—	—	—	—	—	—	—	—	—	1	—	—

Insider Ownership 18.90%

Capital & Financial Ratios $m

Market Cap 421.62

Revenue 11,983.00

Net Income 410.00

Free Cash Flow (182.00)

Net Debt 9,429.00

Current Ratio 1.53

Debt/Equity (8.23)

P/E ratio 1.54

Fwd P/E (5.17)

P/S ratio 0.03

P/B ratio 0.00

Past 5Y EPS Growth (3.00%)

This Y EPS Growth (194.69%)

Next Y EPS Growth 59.01%

Next Y revenue growth (8.31%)

Next 5Y EPS Growth 49.85%

Green and red mark values outside typical ranges. How we judge →

Valuation vs history

EV/Sales, ten years

P/E against its own 10 years 28.47%

10-year low 10-year high

P/S against its own 10 years 32.55%

10-year low 10-year high

EV/Sales against its own 10 years 3.02%

10-year low 10-year high

Dividends

Payout Ratio —

Annual Dividend Rate —

Annual Dividend Yield —

	total	individual payouts
2025	Powerpack
2024	Powerpack
2023	Powerpack
2022	Powerpack
2021	Powerpack
2020	Powerpack
2019	Powerpack
2017	Powerpack

predictions special payouts not included in total or ratios

Assets vs Liabilities $m

	2023	2024	2025	Q'26
Cash	38	37	260	149
Receivables	2,231	2,286	2,077	2,143
Inventory	328	331	322	271
Other	275	358	381	308
	3,208	3,301	3,234	3,081

	2023	2024	2025	Q'26
Payables	912	913	842	713
ST’ Debt	21	20	16	26
Other	—	—	—	—
	2,142	2,345	2,208	2,016

Compound Annual Growth %

	10y	5y	3y
Sales	(4.33%)	1.15%	0.74%
Cash Flow	(5.15%)	(24.26%)	21.87%
Earnings	12.41%	(0.08%)	122.84%
Book Value	0.00%	0.00%	0.00%

Revenue $m

	Mar	Jun	Sep	Dec	Year
’26	2,965	2,825	—	—	—
’25	3,159	3,133	3,087	3,106	12,485
’24	3,140	3,140	3,090	3,264	12,634
’23	3,108	3,115	3,086	3,181	12,490
’22	3,111	2,934	3,025	3,141	12,211
’21	3,013	3,007	3,115	3,233	12,368
’20	3,025	2,519	3,126	3,119	11,789

Fiscal quarters ending in the months shown.

Operating Cash Flow $m

	Mar	Jun	Sep	Dec	Year
’26	(297)	88	—	—	—
’25	120	88	69	266	543
’24	96	101	67	216	480
’23	5	86	29	90	210
’22	101	53	137	9	300
’21	101	179	120	(531)	(131)
’20	57	1,653	392	76	2,178

Fiscal quarters ending in the months shown.

Free Cash Flow $m

	Mar	Jun	Sep	Dec	Year
’26	(373)	12	—	—	—
’25	35	2	7	172	216
’24	4	16	(2)	107	125
’23	(112)	0	(98)	(19)	(229)
’22	4	(34)	67	(114)	(77)
’21	(2)	73	2	(663)	(590)
’20	(42)	1,562	269	(47)	1,742

Fiscal quarters ending in the months shown.

EPS $

	Mar	Jun	Sep	Dec	Year
’26	(0.43)	0.51	—	—	—
’25	(0.10)	2.09	0.96	0.81	3.77
’24	(0.32)	(0.10)	(2.95)	(0.53)	(3.90)
’23	(0.40)	(0.29)	(0.69)	0.35	(1.02)
’22	(0.01)	(2.52)	(0.32)	3.18	0.35
’21	(0.51)	0.04	0.85	1.34	1.76
’20	0.15	0.61	0.97	2.57	4.39

Fiscal quarters ending in the months shown.

Group	Line	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025	2026e
Price, $
Price, $	Low	4.15	3.85	2.48	1.79	2.25	7.01	1.88	2.01	2.51	2.24	Analyst estimates 2026–2028 Powerpack
	High	22.56	10.51	6.36	5.35	11.04	17.04	14.74	8.01	6.29	4.47
People
People	Employees	120,000	113,000	87,000	80,000	70,000	66,000	66,000	61,000	60,000	57,000
	Revenue/emp, $m	0.15	0.14	0.16	0.17	0.17	0.19	0.19	0.20	0.21	0.22
Income, $m
Income, $m	Revenue	18,438	15,353	14,155	13,210	11,789	12,368	12,211	12,490	12,634	12,485
	Gross margin, %	83.67	82.60	83.36	83.72	83.35	83.49	83.83	84.04	84.60	85.07
	EBT	(1,715)	(2,833)	(715)	(430)	422	499	349	207	(283)	724
	EBT margin, %	(9.30)	(18.45)	(5.05)	(3.26)	3.58	4.03	2.86	1.66	(2.24)	5.80
	Net income	(1,626)	(2,396)	(704)	(590)	607	368	179	16	(362)	676
	Depreciation	1,100	861	700	608	558	540	534	505	486	426
Per share, $
Per share, $	Revenue	166.51	137.36	125.57	116.14	102.08	97.57	94.80	95.75	95.64	93.48
	Earnings	(15.54)	(2.00)	(6.99)	(5.93)	4.43	1.82	0.35	(1.02)	(3.90)	3.81
	Cash flow	10.27	6.92	2.43	3.38	18.86	(1.03)	2.33	1.61	3.63	4.07
	Capex	(6.58)	(4.98)	(4.60)	(3.82)	(3.78)	(3.62)	(2.93)	(3.37)	(2.69)	(2.45)
	Free cash flow	3.68	1.93	(2.17)	(0.44)	15.08	(4.65)	(0.60)	(1.76)	0.95	1.62
	Book value	15.61	(6.19)	(12.98)	(18.82)	(13.32)	(10.18)	(9.90)	(8.79)	(12.69)	(8.68)
	Shares, m	111	112	113	114	115	127	129	130	132	134
Valuation, ×
Valuation, ×	P/E	0.00	0.00	0.00	0.00	1.70	7.39	12.22	0.00	0.00	0.82
	P/S	0.03	0.03	0.02	0.03	0.07	0.14	0.05	0.03	0.03	0.03
	P/B	0.37	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
	EV/Sales	0.85	0.90	0.97	1.02	0.97	1.08	0.99	0.95	0.93	0.85
	EV/FCF	38.36	64.12	(55.99)	(270.38)	6.54	(22.58)	(156.93)	(51.80)	94.48	48.86
Cash, $m
Cash, $m	Operating cash flow	1,137	773	274	385	2,178	(131)	300	210	480	543
	Capex	(729)	(557)	(519)	(435)	(436)	(459)	(377)	(439)	(355)	(327)
	Free cash flow	408	216	(245)	(50)	1,742	(590)	(77)	(229)	125	216
Balance, $m
Balance, $m	Working capital	1,779	1,712	1,157	1,145	1,695	1,115	896	1,066	956	1,026
	Total debt	15,244	13,913	13,596	13,405	12,216	12,140	11,635	11,487	11,452	10,396
	Net debt	15,006	13,350	13,400	13,189	10,540	11,633	11,517	11,449	11,415	10,136
	Shareholders’ equity	1,728	(692)	(1,463)	(2,141)	(1,538)	(1,290)	(1,275)	(1,147)	(1,676)	(1,159)
Returns, %
Returns, %	ROA	(7.09)	(12.48)	(4.73)	(4.29)	3.23	1.47	0.31	(0.91)	(3.62)	3.73
	ROIC	(3.21)	(9.27)	1.09	3.68	7.82	8.47	5.01	5.81	3.48	10.36
	ROE	(59.01)	(474.71)	73.13	37.46	(27.78)	(16.27)	(3.59)	10.98	36.56	(35.91)

Negative figures in brackets.

All 10 years →

Fiscal years to Dec 2025 · latest quarter Jun 2026

Charts ten years each

Company	Market cap	P/E	Fwd P/E	Revenue growth (Q)	EPS growth (Q)	FCF growth (Q)	Gross margin (Q)	EBIT margin (Q)	Compare
HCSG Healthcare Services Group, Inc.	$1.5B	12.2×	19.2×	+2.69% (above 0%: growing)	n/m	−26.02% (below 0%: shrinking)	15.89%	4.72%	Compare
NUTX Nutex Health Inc.	$1.4B	7.1×	6.3×	−13.62% (below 0%: shrinking)	n/m	+19.44% (above 0%: growing)	67.04%	57.75%	Compare
USPH U.S. Physical Therapy, Inc.	$1.3B	504×	27.7×	+8.47% (above 0%: growing)	−56.90% (below 0%: shrinking)	−8.24% (below 0%: shrinking)	19.59%	10.25%	Compare
INNV InnovAge Holding Corp.	$1.2B	— (loss-making)	17.2×	+18.31% (above 0%: growing)	n/m	+85.44% (above 0%: growing)	23.88%	3.87%	Compare
STLN Starling Oncology, Inc.	$690.9M	— (loss-making)	— (loss-making)	+34.62% (above 0%: growing)	n/m	+196.69% (above 0%: growing)	16.84%	(2.86%)	Compare
MCTA Charming Medical Limited	$497.3M	—	—	—	—	—	—	—	Compare
CYH Community Health Systems, Inc.	$421.6M	1.5×	— (loss-making)	−9.83% (below 0%: shrinking)	−75.83% (below 0%: shrinking)	+500.00% (above 0%: growing)	85.81%	13.77%
AUNA Auna S.A.	$392.3M	76.0×	5.2×	+20.51% (above 0%: growing)	−61.29% (below 0%: shrinking)	+121.08% (above 0%: growing)	35.72%	13.09%	Compare
SRTA Strata Critical Medical, Inc.	$384.0M	9.0×	— (loss-making)	+60.74% (above 0%: growing)	n/m	+150.33% (above 0%: growing)	20.98%	(7.46%)	Compare
Median of peers	$960.4M	12.2×	17.2×	+18.31%	—	+85.44%	20.98%	4.72%

All 55 Medical Care Facilities stocks →

Community Health Systems, Inc. (CYH) key facts

Concern: Community Health Systems, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $12.5 billion, down 1.18% from fiscal 2024.
Community Health Systems, Inc. (CYH) is a Medical Care Facilities company in the Healthcare sector, listed on the New York Stock Exchange.
As of October 16, 2026, CYH traded at $2.88, a market capitalization of $421.6 million.
Return on equity was −35.9% and debt-to-equity -8.23.
Its Piotroski F-score is 8 out of 9 and its Altman Z-score is 1.05 (distress zone) for fiscal 2025.

Source: company filings (standardised) and stockrow calculations.